Clinical Trial

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to learn about the safety and effects of the study medicine (PF-07328948) for the possible treatment of heart failure (HF).
Protocol Amendment History 2 changes
notable Trial sites expanded: 135 -> 139 locations 2026-05-13
notable Trial sites expanded: 125 -> 130 locations 2026-04-02
Trial Details
NCT Number NCT06991257
Lead Sponsor Pfizer
Conditions Heart Failure
Enrollment 620 participants
Start Date 2025-06-19
Primary Completion 2027-11-16 (estimated)
Study Completion 2027-12-14 (estimated)
Updated on ClinicalTrials.gov 2026-05-27